Trials / Completed
CompletedNCT04477902
Long-Term Experience and Health Effects of COVID-19
A Longitudinal, Long-Term, Observational Study of COVID-19 Experience and Health Effects
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 64 (actual)
- Sponsor
- Altura · Industry
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to gain on-going COVID-19 feedback/data to drive timely action locally and nationally in order to mitigate transmission. Data will be deidentified and consolidated to create a large national longitudinal database.
Detailed description
Ths is a longitudinal, observational, descriptive study to gather data needed to support a better understanding of COVID-19 from the perspective of a diverse national population. This multi-phase study will use an action research approach to identify specific ways that physician groups, federally qualified health centers (FQHCs), public health departments, and other health and social services systems in the United States can address healthcare needs and mitigate the transmission of COVID-19. Email surveys will be used to assess the historical and current status of participants by medical condition, geography, and demographic characteristics, as well as their history of symptoms (e.g. recent cough, fever, loss of sense of taste or smell, etc.) and their current psychosocial needs. The study will provide the structure for an iterative exploration of trends over time (up to 24 months). The opt-in survey will be posted and available to individuals 18 and older who choose to participate. Survey frequency will be every two weeks. To analyze broader trends, all survey responses will be de-identified and aggregated. Overall general findings will not be linked to individuals or physician groups when reporting and publishing study results.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | none - observational | online survey |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2021-06-22
- Completion
- 2021-06-22
- First posted
- 2020-07-20
- Last updated
- 2021-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04477902. Inclusion in this directory is not an endorsement.